Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis

Abstract

Objective: To describe the process underpinning the development of clinical guidelines for the management of behavioural disturbance in psychosis.

Method: A structured process was followed, encompassing a literature review, focus groups with key staff, and pilot testing and monitoring of the guidelines in an acute psychiatric setting.

Results: The process was well accepted by staff and was found useful in monitoring outcomes in a naturalistic setting. The final guidelines proved safe and effective in the acute setting.

Conclusions: The incorporation of a monitoring system for interventions for the management of behavioural disturbance in acute psychiatric settings is beneficial for staff and patients alike.

• antipsychotics
• behavioural disturbance
• benzodiazepines
• clinical practice guidelines
• psychosis